Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent

Bioconjugate Chemistry

Volumn 18, Issue 2, 2007, Pages 379-388

  Stefflova, Klara ^a   Li, Hui ^b   Chen, Juan ^b,c   Zheng, Gang ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; DISEASES; EFFICIENCY; MOLECULAR IMAGING; PHOTODYNAMIC THERAPY; PROBES; TUMORS;

CANCER CELLS; FOLATE RECEPTOR; FOLATES; HT-1080; NORMAL TISSUE; PEPTIDE SEQUENCES; RECEPTOR EXPRESSION; SYNTHESISED; THREE-COMPONENT; WATERSOLUBLE;

PEPTIDES;

FOLATE RECEPTOR; FOLIC ACID; PEPTIDE; PHOTOSENSITIZING AGENT; PYROGLYCYLASPARTYLGLUTAMYLTYROSYLASPARTYLGLYCYLSERYLGLYCYLLYSINE FOLATE; PYROLYSINE FOLATE; PYROPHEOPHORBIDE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER THERAPY; CELL KILLING; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER; MOLECULAR IMAGING; NONHUMAN; ORGAN DISTRIBUTION; PHARMACOMODULATION; PHOTODYNAMIC THERAPY; PROTEIN FUNCTION; SPLEEN;

EID: 33947657338     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0602578     Document Type: Article

References (40)

1. Berg, K., Selbo, P. K., Weyergang, A., Dietze, A., Prasmickaite, L., Bonsted, A., Engesaeter, B. O., Angell-Petersen, E., Warloe, T., Frandsen, N., and Hogset, A. (2005) Porphyrin-related photosensitizers for cancer imaging and therapeutic applications. J. Microsc. 218, 133-147.
2. Licha, K. (2002) Contrast agents for optical imaging. Top. Curr. Chem. 222, 1-29.
3. Oleinick, N. L., and Evans, H. H. (1998) The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat. Res. 150, S146-156.
4. Bogaards, A., Varma, A., Collens, S. P., Lin, A., Giles, A., Yang, V. X., Bilbao, J. M., Lilge, L. D., Muller, P. J., and Wilson, B. C. (2004) Increased brain tumor resection using fluorescence image guidance in a preclinical model. Lasers Surg. Med. 35, 181-190.
5. Coleman, C. N. (2003) Linking radiation oncology and imaging through molecular biology (or now that therapy and diagnosis have separated, it's time to get together again!) Radiology 228, 29-35.
6. Huang, X., El-Sayed, I. H., Qian, W., and El-Sayed, M. A. (2006) Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128, 2115-2120.
7. Dougherty, T. J. (1987) Photosensitizers: therapy and detection of malignant tumors. Photochem. Photobiol. 45, 879-889.
8. Gurfinkel, M., Thompson, A. B., Ralston, W., Troy, T. L., Moore, A. L., Moore, T. A., Gust, J. D., Tatman, D., Reynolds, J. S., Muggenburg, B., Nikula, K., Pandey, R., Mayer, R. H., Hawrysz, D. J., and Sevick-Muraca, E. M. (2000) Pharmacokinetics of ICG and HPPH-car for the detection of normal and tumor tissue using fluorescence, near-infrared reflectance imaging: a case study. Photochem. Photobiol. 72, 94-102.
9. Moon, W. K., Lin, Y., O'Loughlin, T., Tang, Y., Kim, D. E., Weissleder, R., and Tung, C. H. (2003) Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjugate Chem. 14, 539-545.
10. Dougherty, T. J., Gomer, C. J., Henderson, B. W., Jori, G., Kessel, D., Korbelik, M., Moan, J., and Peng, Q. (1998) Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905.
11. Niedre, M. J., Secord, A. J., Patterson, M. S., and Wilson, B. C. (2003) In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy. Cancer Res. 63, 7986-7994.
12. Jori, G. (1996) Tumour photosensitizers: approaches to enhance the selectivity and efficiency of photodynamic therapy. J. Photochem. Photobiol., B 36, 87-93.
13. Chen, J., Stefflova, K., Neidre, M., Wilson, B., Chance, B., Glickson, J. D., and Zheng, G. (2004) Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation. J. Am. Chem. Soc. 126, 11450-11451.
14. Sun, X., and Leung, W. N. (2002) Photodynamic therapy with pyropheophorbide-a methyl ester in human lung carcinoma cancer cell: efficacy, localization and apoptosis. Photochem. Photobiol. 75, 644-651.
15. Bellnier, D. A., Greco, W. R., Loewen, G. M., Nava, H., Oseroff, A. R., Pandey, R. K., Tsuchida, T., and Dougherty, T. J. (2003) Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. Cancer Res. 63, 1806-1813.
16. Reddy, J. A., Allagadda, V. M., and Leamon, C. P. (2005) Targeting therapeutic and imaging agents to folate receptor positive tumors. Curr. Pharm. Biotechnol. 6, 131-150.
17. Lu, Y., and Low, P. S. (2002) Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv. Drug Delivery Rev. 54, 675-693.
18. Sabharanjak, S., and Mayor, S. (2004) Folate receptor endocytosis and trafficking. Adv. Drug Delivery Rev. 56, 1099-1109.
19. Paulos, C. M., Turk, M. J., Breur, G. J., and Low, P. S. (2004) Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis. Adv. Drug Delivery Rev. 56, 1205-1217.
20. Hilgenbrink, A. R., and Low, P. S. (2005) Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J. Pharm. Sci. 94, 2135-2146.
21. Sibrian-Vazquez, M., Jensen, T. J., Hammer, R. P., and Vicente, M. G. (2006) Peptide-mediated cell transport of water soluble porphyrin conjugates. J. Med. Chem. 49, 1364-1372.
22. Rosenkranz, A. A., Jans, D. A., and Sobolev, A. S. (2000) Targeted intracellular delivery of photosensitizers to enhance photodynamic efficiency. Immunol. Cell Biol. 78, 452-464.
23. Dozzo, P., Koo, M. S., Berger, S., Forte, T. M., and Kahl, S. B. (2005) Synthesis, characterization, and plasma lipoprotein association of a nucleus-targeted boronated porphyrin. J. Med. Chem. 48, 357-359.
24. Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57-70.
25. Sharman, W. M., van Lier, J. E., and Allen, C. M. (2004) Targeted photodynamic therapy via receptor mediated delivery systems. Adv. Drug Delivery Rev. 56, 53-76.
26. Konan, Y. N., Gurny, R., and Allemann, E. (2002) State of the art in the delivery of photosensitizers for photodynamic therapy. J. Photochem. Photobiol., B 66, 89-106.
27. Hamblin, M. R., Miller, J, L., and Ortel, B. (2000) Scavenger-receptor targeted photodynamic therapy. Photochem. Photobiol. 72, 533-540.
28. Derycke, A. S., Kamuhabwa, A., Gijsens, A., Roskams, T., De Vos, D., Kasran, A., Huwyler, J., Missiaen, L., and de Witte, P. A. (2004) Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells. J. Natl. Cancer Inst. 96, 1620-1630.
29. Zheng, G., Chen, J., Li, H., and Glickson, J. D. (2005) Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proc. Natl. Acad. Sci. U.S.A. 102, 17757-17762.
30. Morgan, J., Gray, A. G., and Huehns, E. R. (1989) Specific targeting and toxicity of sulphonated aluminium phthalocyanine photosensitised liposomes directed to cells by monoclonal antibody in vitro. Br. J. Cancer 59, 366-370.
31. Chen, X., Hui, L., Foster, D. A., and Drain, C. M. (2004) Efficient synthesis and photodynamic activity of porphyrin-saccharide conjugates: targeting and incapacitating cancer cells. Biochemistry 43, 10918-10929.
32. Farokhzad, O. C., Karp, J. M., and Langer, R. (2006) Nanoparticle-aptamer bioconjugates for cancer targeting. Expert Opin. Drug Delivery 3, 311-324.
33. Ichikawa, K., Hikita, T., Maeda, N., Yonezawa, S., Takeuchi, Y., Asai, T., Namba, Y., and Oku, N. (2005) Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels. Biochim. Biophys. Acta 1669, 69-74.
34. Renno, R. Z., Terada, Y., Haddadin, M. J., Michaud, N. A., Gragoudas, E. S., and Miller, J. W. (2004) Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2. Arch. Opthalmol. 122, 1002-1011.
35. Bisland, S. K., Singh, D., and Gariepy, J. (1999) Potentiation of chlorin e6 photodynamic activity in vitro with peptide-based intracellular vehicles. Bioconjugate Chem. 10, 982-992.
36. Kukowska-Latallo, J. F., Candido, K. A., Cao, Z., Nigavekar, S. S., Majoras, I. J., Thomas, T. P., Balogh, L. P., Khan, M. K., and Baker, J. R., Jr. (2005) Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 65, 5317-5324.
37. Schneider, R., Schmitt, F., Frochot, C., Fort, Y., Lourette, N., Guillemin, F., Muller, J. F., and Barberi-Heyob, M. (2005) Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy. Bioorg. Med. Chem. 13, 2799-2808.
38. Schottelius, M., Rau, F., Reubi, J. C., Schwaiger, M., and Wester, H. J. (2005) Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry. Bioconjugate Chem. 16, 429-437.
39. Zheng, G., Chen, Y., Intes, X., Chance, B., and Glickson, J. D. (2004) Contrast-enhanced near-infrared (NIR) optical imaging for subsurface cancer detection. J. Porphyrins Phthalocyanines 8, 1106-1117.
40. Li, H., Marotta, D. E., Kim, S., Busch, T. M., Wileyto, E. P., and Zheng, G. (2005) High payload delivery of optical imaging and photodynamic therapy agents to tumors using phthalocyanine-reconstituted low-density lipoprotein nanoparticles. J. Biomed. Opt. 10, 41203.